Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Arzneimittel-Forschung|July 1, 1988
Specific binding sites of muroctasin on murine macrophagesM Akasaki, H Masayasu, W Tsukada, et al.Journal of Pharmacobio-Dynamics|July 1, 1990
Mechanism for the inhibitory effect of a seleno-organic compound, Ebselen, and its analogues on superoxide anion production in guinea pig polymorphonuclear leukocytesK Wakamura, T Ohtsuka, N Okamura, et al.The Journal of Pharmacy and Pharmacology|January 1, 1996
Susceptibility of mice to bacterial and fungal infections after intragastric administration of ebselenR Nozawa, M Arai, R Kuruto, et al.Arzneimittel-Forschung|July 1, 1988
Metabolic disposition of 14C-muroctasin in laboratory animalsK Ono, H Masayasu, F Hashimoto, et al.Stroke|August 4, 2001
Ebselen reduces cytochrome c release from mitochondria and subsequent DNA fragmentation after transient focal cerebral ischemia in miceS Namura, I Nagata, S Takami, et al.Neuroscience Letters|February 6, 1995
The neuroprotective efficacy of ebselen (a glutathione peroxidase mimic) on brain damage induced by transient focal cerebral ischaemia in the ratD A Dawson, H Masayasu, D I Graham, et al.Stroke|September 8, 2001
Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemiaH Imai, H Masayasu, D Dewar, et al.Neurological Research|November 5, 1997
Ebselen (DR3305) ameliorates delayed cerebral vasospasm in a canine two-hemorrhage modelT Watanabe, M Nishiyama, T Hori, et al.British Journal of Pharmacology|December 24, 1997
Neuroprotective efficacy of ebselen, an anti-oxidant with anti-inflammatory actions, in a rodent model of permanent middle cerebral artery occlusionT Takasago, E E Peters, D I Graham, et al.Journal of Pharmacobio-Dynamics|October 1, 1987
Inhibition of superoxide anion production in guinea pig polymorphonuclear leukocytes by a seleno-organic compound, ebselenS Ichikawa, K Omura, T Katayama, et al.Pageof 2